PCSK9 Forum is made possible thanks to support from AstraZeneca, LIB Therapeutics, Novartis and Sanofi, all of whom have no influence or control of editorial content. More information is available here »

Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

14th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 9th June 2021 (Educational supporters)

PCSK9 inhibition: The evolving treatment paradigm post-MI – A perspective from Professor Gregory Schwartz

PCSK9 inhibition: The evolving treatment paradigm post-MI – A perspective from Professor Gregory Schwartz

Reports from the 14th Virtual Closed Scientific Expert Meeting of the Editorial Board  Professor Gregory Schwartz 

read more »
PCSK9 inhibition: The evolving treatment paradigm post-MI – A perspective from Professor Robert Giugliano

PCSK9 inhibition: The evolving treatment paradigm post-MI – A perspective from Professor Robert Giugliano

Reports from the 14th Virtual Closed Scientific Expert Meeting of the Editorial Board Professor Robert Giugliano 

read more »
Low lipoprotein(a): Is there any potential risk?

Low lipoprotein(a): Is there any potential risk?

Reports from the 14th Virtual Closed Scientific Expert Meeting of the Editorial Board Dr Anne Langsted 

read more »
Cholesterol crystals, plaque stability and ASCVD

Cholesterol crystals, plaque stability and ASCVD

Reports from the 14th Virtual Closed Scientific Expert Meeting of the Editorial Board Professor John Chapman 

read more »
Bempedoic acid: An update on the trials

Bempedoic acid: An update on the trials

Reports from the 14th Virtual Closed Scientific Expert Meeting of the Editorial Board Dr Erik Stroes 

read more »
Attaining LDL cholesterol goal: Triple combination strategies

Attaining LDL cholesterol goal: Triple combination strategies

Reports from the 14th Virtual Closed Scientific Expert Meeting of the Editorial Board Dr Michel Farnier 

read more »